NON METASTATIC BREAST CANCER
Clinical trials for NON METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new NON METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for NON METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug may shield hearts of breast cancer patients during chemo
Disease control Recruiting nowThis study tests whether adding azeliragon to standard chemotherapy can reduce heart damage and mental decline in women with early breast cancer. About 48 participants will receive the drug alongside chemo to see if it is safe and effective. The goal is to make cancer treatment s…
Matched conditions: NON METASTATIC BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Can mindfulness ease the burden of breast cancer? new trial seeks answers
Symptom relief Recruiting nowThis study tests a program called MAEva, which combines meditation and acceptance techniques, to see if it helps women with non-metastatic breast cancer feel better emotionally and physically. About 190 participants will either join the MAEva program or a discussion group for nin…
Matched conditions: NON METASTATIC BREAST CANCER
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated May 26, 2026 11:47 UTC
-
Cold gloves plus pressure may shield nerves during breast cancer chemo
Symptom relief Recruiting nowThis study tests whether using a frozen glove plus a tight surgical glove on one hand works better than a frozen glove alone to prevent nerve damage from paclitaxel chemotherapy in breast cancer patients. About 60 women with early-stage breast cancer will each serve as their own …
Matched conditions: NON METASTATIC BREAST CANCER
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated May 26, 2026 11:46 UTC